1. Inhibition of AMP-activated protein kinase in respiratory syncytial virus infection activates lipid metabolism.
- Author
-
González-García LD, Martínez-Castillo M, Vargas-Pavía TA, Ulloa-Aguilar JM, Arévalo-Romero H, Léon-Reyes G, Helguera-Repetto AC, García-Cordero J, and León-Juárez M
- Subjects
- AMP-Activated Protein Kinases metabolism, Cell Line, Tumor, Humans, Proto-Oncogene Proteins c-akt metabolism, Virus Replication, AMP-Activated Protein Kinases antagonists & inhibitors, Lipid Metabolism, Respiratory Syncytial Virus Infections metabolism, Respiratory Syncytial Virus, Human physiology
- Abstract
Respiratory syncytial virus (RSV) is most commonly associated with upper respiratory tract infections during childhood. The lipid composition of cells and lipogenic enzymes play an important role in RSV infection. There are controversial data about whether lipid biosynthesis regulators such as AMP-activated protein kinase (AMPK) are deregulated by RSV. Hence, we examined whether the activation state of AMPK is altered in RSV-infected HEp-2 cells. Our data show that RSV infection inhibits AMPK activity, favoring the activation of downstream lipogenic effectors and cellular lipid anabolism in HEp-2 cells.
- Published
- 2021
- Full Text
- View/download PDF